Circulating Tumor DNA Based Minimal Residual Disease Detection and Adjuvant Treatment Decision-Making for Muscle-Invasive Bladder Cancer Guided by Modern Clinical Trials – Beyond the Abstract
bladder cancer, Circulating Tumor DNA (ctDNA), Residual Disease Detection, imvigor010 study, immunotherapy, adjuvant therapy, urine tumor DNA markers, treatment of invasive bladder cancer.